DONNA

TapImmune Approved for Listing on the Nasdaq Capital Market

November 5th, 2016 | Posted In: Research Updates

Closer to the Finish!  DONNA partner TapImmune announced that its common stock has been approved to begin trading on The Nasdaq Capital Market.  The company’s common stock will begin trading under the symbol “TPIV” at the opening of trading on Tuesday, November 8, 2016.

Leave a Reply

Be the First to Comment!

Notify of
wpDiscuz

Stay Posted

Stay Posted

Locals Rule

Locals Rule

YesWay

YesWay

Team Donna

Team Donna

Donna partners

The Donna Foundation

The Donna Foundation

Jeff Galloway

Jeff Galloway

Mayo Clinic

Mayo Clinic

Learn More

First Coast News